EFFICACY AND SAFETY OF THE USE OF CETUXIMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER

被引：0
|
作者：
Croci, A. [1 ]
Aleman, A. [1 ]
Perez Galan, A. [1 ]
机构：
[1] Minist Publ Hlth, Montevideo, Uruguay
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.230
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN2
引用
收藏
页码：A815 / A815
页数：1
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF CETUXIMAB PLUS IRINOTECAN IN IRINOTECAN-REFRACTORY ELDERLY PATIENTS (>65 YEARS) WITH METASTATIC COLORECTAL CANCER (MCRC)
    Jehn, C.
    Stenzel, K.
    Boening, L.
    Kroening, H.
    Possinger, K.
    Lueftner, D.
    ANNALS OF ONCOLOGY, 2010, 21 : 195 - 195
  • [42] Efficacy and safety of Cetuximab plus irinotecan in irinotecan-refractory elderly patients (>65 years) with metastatic colorectal cancer (mCRC)
    Jehn, C.
    Stenzel, K.
    Boening, L.
    Kroening, H.
    Possinger, K.
    Lueftner, D.
    ONKOLOGIE, 2010, 33 : 174 - 174
  • [43] Real-world Safety and Efficacy of Raltitrexed in Patients With Metastatic Colorectal Cancer
    Batra, Atul
    Rigo, Rodrigo
    Hannouf, Malek B.
    Cheung, Winson Y.
    CLINICAL COLORECTAL CANCER, 2021, 20 (02) : E75 - E81
  • [44] Efficacy and safety of apatinib in patients with metastatic colorectal cancer refractory to standard therapies
    Lv, Wangxia
    Yuan, Meiqin
    Zhao, Yazheng
    Shi, Zhong
    Yang, Yunshan
    Zhong, Haijun
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (02) : 420 - 427
  • [45] Safety and efficacy of nintedanib for the treatment of metastatic colorectal cancer
    Carmen Riesco-Martinez, Maria
    Sanchez-Torre, Ana
    Garcia-Carbonero, Rocio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (11) : 1295 - 1305
  • [46] The safety and efficacy of ramucirumab for the treatment of metastatic colorectal cancer
    Diaz-Serrano, Asuncion
    Riesco-Martinez, Maria C.
    Garcia-Carbonero, Rocio
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (06) : 585 - 595
  • [47] Safety and Efficacy of Panitumumab in the Treatment of Metastatic Colorectal Cancer
    Freeman, Daniel J.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 633 - 645
  • [48] Polymorphisms within Immune Regulatory Pathways Predict Cetuximab Efficacy and Survival in Metastatic Colorectal Cancer Patients
    Volz, Nico B.
    Hanna, Diana L.
    Stintzing, Sebastian
    Zhang, Wu
    Yang, Dongyun
    Cao, Shu
    Ning, Yan
    Matsusaka, Satoshi
    Sunakawa, Yu
    Berger, Martin D.
    Cremolini, Chiara
    Loupakis, Fotios
    Falcone, Alfredo
    Lenz, Heinz-Josef
    CANCERS, 2020, 12 (10) : 1 - 18
  • [49] Effects of p16 methylation on the efficacy of cetuximab in metastatic colorectal cancer
    Kim, Ki Hyang
    Park, Kyu Hyun
    Chang, Hyun
    Kim, Hyo Song
    Shin, Sang Joon
    Rha, Sun Young
    Chung, Hyun Cheol
    Roh, Jae Kyung
    Ahn, Joong Bae
    CANCER RESEARCH, 2011, 71
  • [50] Genes involved in EGFR-degradation to predict for efficacy in metastatic colorectal cancer patients treated with cetuximab
    Stintzing, Sebastian
    Zhang, Wu
    Wakatsuki, Takeru
    Ning, Yan
    Volz, Nico Benjamin
    Li, Joseph Ethan
    Labonte, Melissa Janae
    Wilson, Peter M. D.
    Kardosh, Adel
    Loupakis, Fotios
    Salvatore, Lisa
    Schirripa, Marta
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345